Current Opinion in Urology

Papers
(The TQCC of Current Opinion in Urology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The role of innovations in advancing urologic oncologic patient care56
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma43
The adverse impact of COVID-19 on men's health35
Best nonsurgical managements of acute urinary retention: what's new?31
Editorial introductions22
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies20
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis20
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology19
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker19
Research frontiers in urology19
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects19
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments18
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update18
Editorial: Medical, technical and functional aspect of various types of urinary diversion18
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma17
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations16
Tissue-based gene expression testing in localized prostate cancer16
RNA-based urinary assays for non-muscle invasive bladder cancer15
Editorial introductions15
Sustainable practices in hospital and operating theaters15
Editorial introductions15
Editorial introductions13
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder13
Testicular cancer with small metastatic burden: optimal approach in 202412
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors12
Optimizing clinical risk stratification of localized prostate cancer12
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging11
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects11
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints11
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancer11
Sexually transmitted infections and the vaginal microbiome after vaginoplasty10
Update on classification of oncocytic neoplasms of the kidney10
Management of vaginoplasty canal complications9
Risk of dementia associated with the use of anticholinergic medications: a review of recent literature9
Metabolic syndrome, obesity and cancer risk9
Is there a role for metastasis-directed therapy in bladder cancer?9
Brief update of the new WHO classification for urothelial carcinoma9
Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature9
Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?9
Preoperative geriatric assessment of urological patients: a narrative review8
Retrograde intra renal surgery and safety: pressure and temperature. A systematic review8
Preoperative patient optimization for endourological procedures: the current best clinical practice8
The role of radiotherapy in pelvic nodal recurrence following definitive treatment for prostate cancer8
Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities8
Toxicities of taxane-based chemotherapy in prostate cancer8
Patient-reported outcomes in genital gender-affirming surgery8
Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma8
Decoding germ cell tumours for clinicians7
Are robots the future? A case for robotic pyeloplasty as the gold standard treatment in ureteropelvic junction obstruction7
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer7
MR-guided radiotherapy for prostate cancer: an inevitable transition?7
The role of surgery for locally advanced urothelial cancers7
Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapies7
Medical therapy for male infertility7
Liquid biomarkers in prostate cancer: recent advancements and future directions7
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors7
Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis7
Metastasis-directed therapy in oligometastatic and oligoprogressive renal cell carcinoma7
Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance7
Lasers for benign prostatic hyperplasia (hybrid, blue diode, TFL, Moses). Which one to choose?6
Editorial introductions6
Use of genomic markers to improve epidemiologic and clinical research in urology6
Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer6
AI-powered radiomics: revolutionizing detection of urologic malignancies6
Percutaneous management of caliceal diverticula: a narrative review6
Innovative systemic therapies for penile cancer6
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes6
Editorial introductions6
Advanced sperm tests and impact on clinical male factor management5
Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis5
Surgical management of testicular cancer with limited retroperitoneal disease5
Ultra-hypofractionation for the treatment of macroscopic prostate bed recurrence: a focus on stereotactic radiotherapy and brachytherapy5
The use of MRI in urothelial carcinoma5
Implications and effects of COVID-19 on diagnosis and management of prostate cancer5
Digital health innovations in urology: telemedicine, wearables, and mobile applications – a systematic review of literature5
Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers5
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population5
The environmental impacts of anesthesia5
Inflammation and kidney stones: cause and effect?5
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysis5
Overlooked and underserved: how healthcare fails men in the pursuit of equity5
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era5
Detection of urological cancers by the signature of organic volatile compounds in urine, from dogs to electronic noses5
Does surgical removal of kidney stones help prevent the recurrence of urinary tract infections? A systematic review4
The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers4
Editorial introductions4
Preclinical models for bladder cancer therapy research4
Leveraging behavioral modification technology for the prevention of kidney stones4
Editorial introductions4
New technologies for nephron-sparing surgery in upper urinary tract cancers4
Advances in ureteral stent technology4
Endo-technology and its future: where are we heading?4
Transperineal vs. transrectal biopsy to reduce postinterventional sepsis4
The urothelial barrier in interstitial cystitis/bladder pain syndrome: its form and function, an overview of preclinical models4
Robotic sacrocolpopexy in pelvic organ prolapse: a review of current literature4
Current position of neuromodulation for bladder pain syndrome/interstitial cystitis4
Management of stage I testicular cancer4
Genetics of testicular cancer: a review4
What’s in a name? Why differentiation between biochemical recurrence and metastatic prostate cancer matters4
Metabolic evaluation: is there really a future?4
Novel intravesical delivery systems for nonmuscle invasive bladder cancer4
En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference?4
The role of radical cystectomy and lymphadenectomy in the management of bladder cancer with clinically positive lymph node involvement4
How to present quality of life outcomes after focal therapy: using validated instruments and novel statistical methods4
Editorial introductions4
Pelvic pain syndromes4
Editorial: Future of kidney stone management4
Integration of novel artificial intelligence tools in pediatric urologic practice4
Role of cytoreductive surgery in the era of immunotherapy4
Organ storage in renal transplantation4
The role of surgical resection of the primary tumor in metastatic upper tract urothelial carcinoma: a systematic review and meta-analysis4
Integration of prostate-specific membrane antigen-PET and multiparametric MRI for gross tumour volume definition in localised and locally advanced prostate cancer treated with image-guided radiotherap4
Medical management of male infertility: now and future4
0.14184784889221